- Article
Radionuclide-Dependent Stimulation of Antitumor Immunity in GD2-Targeted Radiopharmaceutical Therapy Combined with Immune Checkpoint Inhibitors
- Cynthia Lilieholm,
- Jen Zaborek,
- Ohyun Kwon,
- Adedamola O. Adeniyi,
- Caroline P. Kerr,
- Hansel Comas Rojas,
- Malick Bio Idrissou,
- Carolina A. Ferreira,
- Paul A. Clark and
- Jamey P. Weichert
- + 10 authors
Radiopharmaceutical therapy (RPT) offers tumor-selective radiation delivery and represents a promising platform for combination with immune checkpoint inhibitors (ICIs). While prior studies suggest that RPT can stimulate antitumor immunity, synergy w...

